1. Home
  2. IMRX vs EMF Comparison

IMRX vs EMF Comparison

Compare IMRX & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$5.32

Market Cap

322.8M

Sector

Health Care

ML Signal

HOLD

Logo Templeton Emerging Markets Fund

EMF

Templeton Emerging Markets Fund

HOLD

Current Price

$18.79

Market Cap

311.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRX
EMF
Founded
2008
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
322.8M
311.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IMRX
EMF
Price
$5.32
$18.79
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$17.20
N/A
AVG Volume (30 Days)
687.8K
63.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
6.16%
EPS Growth
37.75
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$11.14
52 Week High
$10.08
$21.20

Technical Indicators

Market Signals
Indicator
IMRX
EMF
Relative Strength Index (RSI) 54.60 35.58
Support Level $3.93 $16.13
Resistance Level $5.36 $20.30
Average True Range (ATR) 0.28 0.39
MACD 0.04 -0.29
Stochastic Oscillator 84.82 7.22

Price Performance

Historical Comparison
IMRX
EMF

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About EMF Templeton Emerging Markets Fund

Templeton Emerging Markets Fund is a closed-end management investment company that seeks long-term capital appreciation by investing mainly in emerging country equity securities under normal market conditions. It invests across various sectors, including Pharmaceuticals, Beverages, Broadline Retail, Metals & Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, Insurance, Entertainment, and others.

Share on Social Networks: